Morales‐Ortega, A., García de Tena, J., Frutos‐Pérez, B., Jaenes‐Barrios, B., Farfán‐Sedano, A. I., Canales‐Albendea, M. Á., & Bernal‐Bello, D. (2021). COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors. Cancer.
Chicago-tyylinen lähdeviittausMorales‐Ortega, Alejandro, Jaime García de Tena, Begoña Frutos‐Pérez, Beatriz Jaenes‐Barrios, Ana Isabel Farfán‐Sedano, Miguel Ángel Canales‐Albendea, ja David Bernal‐Bello. "COVID‐19 in Patients With Hematological Malignancies: Considering the Role of Tyrosine Kinase Inhibitors." Cancer 2021.
MLA-viiteMorales‐Ortega, Alejandro, et al. "COVID‐19 in Patients With Hematological Malignancies: Considering the Role of Tyrosine Kinase Inhibitors." Cancer 2021.